Abbott Laboratories (ABT) Q3 2021 Earnings Call Transcript
ABT earnings call for the period ending September 30, 2021.
Stay updated with breaking news from Structural Heart. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ABT earnings call for the period ending September 30, 2021.
/PRNewswire/ -- Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2021. Third-quarter sales of $10.9 billion increased...
/PRNewswire/ -- Peijia Medical (HKEX:9996, or "Peijia"), a leading player in China for medical technology, announced a partnership with inQB8, a Boston based...
/PRNewswire/ -- Peijia Medical (HKEX:9996, or "Peijia"), a leading player in China for medical technology, announced a partnership with inQB8, a Boston based...
AdjuCor Raises € 29 Million in Series B Funding Round for its Revolutionary Heart Assist Technology that Completely Avoids Blood Contact Share Article AdjuCor raises € 29 million to enable its next phase of bringing its revolutionary heart assist technology to the severely underserved end-stage heart failure patients. This Series B financing round includes € 25 million from the cardiovascular-focused medical device platform company MitrAssist Holdings Limited accompanied by an additional € 4 million from the returning investor Maurizio Group. AdjuCor's revolutionary technology provide...